{"schema_version":"secwatch.filing_event.v1","accession":"0000950142-23-000435","form_type":"8-K","ticker":"AMN","cik":"0001142750","company_name":"AMN HEALTHCARE SERVICES INC","filed_at":"2023-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.979281+00:00","generated_at":"2026-06-19T08:48:28.840097+00:00","sec_items":["2.02","2.03","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AMN Healthcare Q4 revenue down 17%, EPS down 22%; credit facility expanded to $750M","bullets":["Q4 revenue $1.126B (-17% YoY); GAAP EPS $1.88 (-22%), adjusted EPS $2.48 (-16%).","Full year 2022 revenue $5.24B (+32% YoY); GAAP EPS $9.90 (+45%), adjusted EPS $11.90 (+48%).","Q4 revenue exceeded high end of guidance by 4%.","Credit agreement amended: revolver increased to $750M, maturity extended to Feb 2028, SOFR + 1.00%-1.75%.","Share repurchase program increased (no dollar amount disclosed in provided text)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950142-23-000435","json":"https://secwatch.observer/filing/0000950142-23-000435.json","markdown":"https://secwatch.observer/filing/0000950142-23-000435.md","text":"https://secwatch.observer/filing/0000950142-23-000435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1142750/000095014223000435/0000950142-23-000435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1142750/000095014223000435/eh230330592_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T08:48:28.840097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3cd4974172a2b23d1269770bac4addde5a50091f","claim":"AMN HEALTHCARE SERVICES INC amended revolving credit of $750,000,000 with Truist Bank at SOFR based interest rate with a spread of 1.00% to 1.75% maturing February 10, 2028.","evidence_excerpt":"Ratio, as calculated quarterly in accordance with the Credit Agreement), (iii) the revolving commitments were increased by $350,000,000 for total revolving commitments of $750,000,000, (iv) the maximum LOC Obligations permitted to be outstanding were increased by $50,000,000 for a total of $125,000,000, (v) terms related to the Tranche A Loans were removed,","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1142750/000095014223000435/0000950142-23-000435-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"$750,000,000"},{"label":"Counterparty","value":"Truist Bank"},{"label":"Rate","value":"SOFR based interest rate with a spread of 1.00% to 1.75%"},{"label":"Maturity","value":"February 10, 2028"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"68a0ea20752e6e1a581ace65a29fd4149968878b","claim":"AMN HEALTHCARE SERVICES INC reported financial results for the fiscal quarter and year ended December 31, 2022.","evidence_excerpt":"On February 16, 2023, AMN Healthcare Services, Inc. (“AMN”) reported its results for the fiscal quarter and year ended December 31, 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1142750/000095014223000435/0000950142-23-000435-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter and year ended December 31, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}